Masuda N, Yasojima H, Bando H, Yamanaka T, et al. Long-term outcomes of eribulin?based neoadjuvant chemotherapy for triple?negative breast cancer patients stratified by homologous recombination deficiency status: results of the randomized JBCRG-22 study. Breast Cancer Res Treat 2026;216:31.
PMID: 41854792